Fundraising FoxSenesys
1 known investors
Find your way into Senesys
Sign up to see every warm intro you have to Senesys
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Senesys team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Senesys.Bio develops NanoJAGGs, a nanostructure-based delivery platform that targets and eliminates senescent cells to treat age-related and chronic diseases. The nanostructures selectively localize to senescent cells and can be configured to carry a range of therapeutic molecules, including senolytics, antioxidants, small drugs, and biomolecules.
Investors · 1
Frequently asked questions
- What does Senesys do?
- Senesys.Bio develops NanoJAGGs, a nanostructure-based delivery platform that targets and eliminates senescent cells to treat age-related and chronic diseases. The nanostructures selectively localize to senescent cells and can be configured to carry a range of therapeutic molecules, including senolytics, antioxidants, small drugs, and biomolecules.
- Who are Senesys's investors?
- Senesys's investors include University of Cambridge Enterprise.